Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:47 AM EDT

Mosaic ImmunoEngineering (CPMV) EBIT Margin (2010 - 2011)

Updated

Mosaic ImmunoEngineering (CPMV) recorded EBIT Margin of -1641.83% in Q2 2012, up 751.91 percentage points from -2393.73% a year earlier but down 1043.43 percentage points from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) EBIT Margin (2010 - 2011) Analysis & Trends

On a TTM basis, Mosaic ImmunoEngineering's EBIT Margin came in at 214.65% as of Nov 30, 2011.

  • Quarterly EBIT Margin has ranged from -2393.73% in Q2 2011 to -598.40% in Q1 2012 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Mosaic ImmunoEngineering 441,423.27 352,385.27 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 -1,641.83%
Aug 31, 2011 -598.40%
Nov 30, 2010 -2,393.73%
Aug 31, 2010 -1,684.65%
API Access

Mosaic ImmunoEngineering EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CPMV&period=max&api_key=YOUR_API_KEY